NYSE:FMS Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, News & Analysis $22.50 -0.26 (-1.12%) Closing price 10/27/2026 03:59 PM EasternExtended Trading$22.46 -0.03 (-0.15%) As of 04:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Fresenius Medical Care AG & Co. KGaA Stock (NYSE:FMS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get FMS alerts:Sign Up Key Stats Today's Range$22.48▼$22.6750-Day Range$20.69▼$23.8852-Week Range$20.02▼$27.40Volume784,303 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice Target$23.43Consensus RatingReduce Company Overview Fresenius Medical Care AG & Co. KGaA is a Germany-based health care company focused on the treatment of chronic kidney failure. The company provides dialysis care for patients with end-stage renal disease through a network of outpatient dialysis clinics and other health care facilities. In addition to operating dialysis centers, Fresenius Medical Care develops and supplies products used in dialysis treatment. Its portfolio includes hemodialysis machines, dialyzers, dialysis solutions, bloodlines, and related medical devices and services. The company also provides clinical care, care coordination, and other services intended to support patients with chronic kidney disease. Headquartered in Bad Homburg, Germany, Fresenius Medical Care serves patients and health care providers across multiple international markets, with a substantial presence in North America and Europe as well as operations in other regions. The company was established in 1996 through the combination of Fresenius Worldwide Dialysis and National Medical Care.AI Generated. May Contain Errors. Read More Fresenius Medical Care AG & Co. KGaA Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScoreFMS MarketRank™: 2.05348743448 of 5 starsFresenius Medical Care AG & Co. KGaA scored higher than 41% of companies evaluated by MarketBeat, and ranked 235th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingReduce Consensus RatingFresenius Medical Care AG & Co. KGaA has received a consensus rating of Reduce. The company's average rating score is 1.64, and is based on no strong buy ratings, no buy ratings, 7 hold ratings, and 4 sell ratings.Upside/DownsideThe consensus price target for Fresenius Medical Care AG & Co. KGaA is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageFresenius Medical Care AG & Co. KGaA has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fresenius Medical Care AG & Co. KGaA's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth5.36% Earnings GrowthEarnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 5.36% in the coming year, from $2.24 to $2.36 per share.Read more about Fresenius Medical Care AG & Co. KGaA's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.74% of the float of Fresenius Medical Care AG & Co. KGaA has been sold short.Short Interest Ratio / Days to CoverFresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 3.51, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 39.71%, indicating that investor sentiment is decreasing significantly. Dividend0.8 / 5Dividend StrengthN/A Dividend YieldFresenius Medical Care AG & Co. KGaA does not currently pay a dividend.Dividend GrowthFresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 25.42% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend. News and Social Media3.9 / 5News Sentiment1.19 News SentimentFresenius Medical Care AG & Co. KGaA has a news sentiment score of 1.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Fresenius Medical Care AG & Co. KGaA this week, compared to 1 article on an average week.Search Interest3 people have searched for FMS on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.Percentage Held by Institutions8.37% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions.Read more about Fresenius Medical Care AG & Co. KGaA's insider trading history. Receive FMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FMS Stock News HeadlinesFMS launches multiFiltratePRO system for US patients with acute AKIOctober 23, 2026 | msn.comFinancial Review: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) & HealthEquity (NASDAQ:HQY)October 20, 2026 | americanbankingnews.comHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end. | Banyan Hill Publishing (Ad)Goldman Sachs Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)October 7, 2026 | theglobeandmail.comShervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growthOctober 7, 2026 | marketscreener.comMFresenius Medical Care: Margin Expansion Supports The Story, But Growth Remains LimitedOctober 7, 2026 | seekingalpha.comJefferies Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)August 9, 2026 | theglobeandmail.comBernstein Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)August 9, 2026 | theglobeandmail.comSee More Headlines FMS Stock Analysis - Frequently Asked Questions How have FMS shares performed this year? Fresenius Medical Care AG & Co. KGaA's stock was trading at $23.84 at the start of the year. Since then, FMS stock has decreased by 5.6% and is now trading at $22.4950. How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its earnings results on Monday, August, 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.04. The firm had revenue of $5.55 billion for the quarter, compared to the consensus estimate of $5.48 billion. Read the conference call transcript. Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries? The following companies are subsidiaries of Fresenius Medical Care AG & Co. KGaA: NxStage Medical. Who are Fresenius Medical Care AG & Co. KGaA's major shareholders? Top institutional investors of Fresenius Medical Care AG & Co. KGaA include Crossmark Global Holdings Inc. (0.01%), Quadrant Capital Group LLC (0.01%), DMC Group LLC and GAMMA Investing LLC. How do I buy shares of Fresenius Medical Care AG & Co. KGaA? Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care AG & Co. KGaA investors own include JPMorgan Chase & Co. (JPM), AT&T (T), Energy Transfer (ET), Coca-Cola (KO), Fresenius Medical Care (FME), Cisco Systems (CSCO) and Alphabet (GOOG). Company Calendar Last Earnings8/03/2026Today10/28/2026Next Earnings (Estimated)11/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 As of 5 days ago, FMS's financial health entered the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:FMS CIK1333141 Webwww.freseniusmedicalcare.com Phone(496) 172-6090Fax49-6172-609-2301Employees1,488Year Founded1912Price Target and Rating Average Price Target for Fresenius Medical Care AG & Co. KGaA$23.43 High Price Target$25.80 Low Price Target$19.90 Potential Upside/Downside+4.1%Consensus RatingReduce Rating Score (0-4)1.64 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NYSE:FMS) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredYesterday's deadline changed everythingIn June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times th...Behind the Markets | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius Medical Care AG & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius Medical Care AG & Co. KGaA With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
